Get the Stockscreener App
26.69
5.41%
1.37
After Hours:
26.69
Staar Surgical Co stock is traded at $26.69, with a volume of 1.57M.
It is up +5.41% in the last 24 hours and down -2.02% over the past month.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
See More
Previous Close:
$25.32
Open:
$25.42
24h Volume:
1.57M
Relative Volume:
0.95
Market Cap:
$1.32B
Revenue:
$224.45M
Net Income/Loss:
$-95.27M
P/E Ratio:
-13.83
EPS:
-1.93
Net Cash Flow:
$-43.74M
1W Performance:
-1.49%
1M Performance:
-2.02%
6M Performance:
+61.46%
1Y Performance:
-13.03%
1-Day Range:
$24.95
$26.78
1-Week Range:
$23.85
$26.91
52-Week Range:
$13.50
$32.00
Staar Surgical Co Stock (STAA) Company Profile
Name
Staar Surgical Co
Sector
Industry
Phone
(626) 303-7902
Address
1911 WALKER AVE, MONROVIA, CA
Compare STAA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
26.69 | 1.25B | 224.45M | -95.27M | -43.74M | -1.93 |
|
ISRG
Intuitive Surgical Inc
|
462.74 | 164.35B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
189.03 | 54.75B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
268.22 | 39.61B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
75.76 | 37.31B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
279.39 | 19.77B | 2.96B | 487.70M | 344.00M | 6.6758 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-25 | Initiated | Wells Fargo | Equal Weight |
| Feb-12-25 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-12-25 | Downgrade | Jefferies | Buy → Hold |
| Feb-12-25 | Downgrade | Mizuho | Outperform → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-11-24 | Upgrade | BTIG Research | Neutral → Buy |
| Mar-11-24 | Upgrade | Stifel | Hold → Buy |
| Dec-05-23 | Downgrade | Needham | Buy → Hold |
| Dec-04-23 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-03-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jun-07-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-17-23 | Initiated | Piper Sandler | Neutral |
| Feb-06-23 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-28-22 | Reiterated | BTIG Research | Buy |
| Dec-08-22 | Initiated | Stifel | Hold |
| Nov-07-22 | Upgrade | Sidoti | Neutral → Buy |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-28-22 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-18-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-09-21 | Initiated | Oppenheimer | Perform |
| Jan-19-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Oct-26-20 | Downgrade | Sidoti | Buy → Neutral |
| Aug-31-20 | Upgrade | Sidoti | Neutral → Buy |
| Aug-06-20 | Reiterated | The Benchmark Company | Buy |
| Jul-06-20 | Downgrade | Sidoti | Buy → Neutral |
| Jun-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-15-20 | Initiated | Jefferies | Buy |
| Dec-04-19 | Initiated | BTIG Research | Buy |
| Sep-24-18 | Reiterated | The Benchmark Company | Buy |
| Aug-06-18 | Resumed | The Benchmark Company | Buy |
| Nov-20-17 | Reiterated | The Benchmark Company | Buy |
| Aug-14-17 | Reiterated | The Benchmark Company | Buy |
| Mar-03-17 | Reiterated | The Benchmark Company | Buy |
| May-18-16 | Upgrade | The Benchmark Company | Hold → Buy |
| Sep-10-13 | Resumed | The Benchmark Company | Buy |
| Feb-28-13 | Reiterated | The Benchmark Company | Buy |
| Nov-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-02-12 | Initiated | Northland Securities | Outperform |
| Oct-25-11 | Reiterated | The Benchmark Company | Buy |
| Oct-12-10 | Initiated | Morgan Joseph | Buy |
| May-11-10 | Initiated | Benchmark | Buy |
View All
Staar Surgical Co Stock (STAA) Latest News
Global Cataract Surgery Devices Market to Grow at a CAGR of - GlobeNewswire
STAAR Surgical Q3 2025 preliminary net sales up 6.9% to USD 94.7M - Medical Buyer
Yunqi Capital Issues Letter to Board of Directors of Staar Opposing Alcon Acquisition - MarketScreener
Yunqi Capital reiterates opposition to STAAR Surgical-Alcon merger By Investing.com - Investing.com Canada
Yunqi Capital issues letter to Staar Surgical's board calling for timely convening of special meeting to vote on Alcon transaction - MarketScreener
STAAR Surgical earnings missed by $0.02, revenue topped estimates - Investing.com
Proxy firms and shareholders oppose STAAR Surgical acquisition by Alcon - Investing.com
STAAR Surgical rises premarket after Q3 prelim sales beat - TradingView
STAAR Surgical Topped Estimates, But Analysts Still Hold Back - Finimize
Broadwood Partners Highlights Growing Opposition to STAAR Surgical’s Proposed Sale to Alcon - MarketScreener
Broadwood Partners Provides Information to Shareholders of STAAR Surgical - MarketScreener
STAA Reports Growth in Net Sales Fueled by December Shipment - GuruFocus
STAAR Surgical (STAA) Releases Q3 Sales Data Exceeding Expectati - GuruFocus
STAAR Surgical reports preliminary Q3 net sales up 6.9% to $94.7 million - Investing.com
STAAR Surgical prelim Q3 sales beat estimates, boosted by deferred China shipment - MarketScreener
STAAR Surgical Announces Preliminary Net Sales Results for Third Quarter 2025 - MarketScreener
What data driven models say about STAAR Surgical Company’s futureWeekly Trend Recap & AI Driven Stock Movement Reports - newser.com
STAAR Surgical says no other acqusition proposals other than Alcon - MSN
Broadwood urges STAAR board to proceed with acquisition vote By Investing.com - Investing.com Nigeria
Broadwood urges STAAR board to proceed with acquisition vote - Investing.com
27.5% owner Broadwood urges STAAR Surgical shareholders to vote "AGAINST" Alcon sale; vote Oct 23, 2025 - Stock Titan
STAAR Surgical Company (STAA) Stock Analysis: Navigating Growth Challenges and Investment Potential - DirectorsTalk Interviews
Can STAAR Surgical Company stock resist market sell offs2025 Market Overview & AI Enhanced Execution Alerts - newser.com
ISS recommendation may toll the bell for STAAR–Alcon deal, validates Broadwood - Investing.com
STAAR Surgical (STAA): A Fresh Look at Valuation After Recent Share Price Pullback - simplywall.st
STAAR Surgical (STAA) Urges Stockholders to Support Alcon Merger - GuruFocus
STAAR disputes Broadwood’s claims about acquisition offers - Investing.com India
STAAR disputes Broadwood’s claims about acquisition offers By Investing.com - Investing.com Nigeria
Independent Poxy Advisory Firms Issues Recommendations to Shareholders of Broadwood Partners - MarketScreener
Midday Stock Roundup: Eledon up 16% on Kidney Presentation - Orange County Business Journal
Staar sale to Alcon eclipsed by shareholder, proxy advisor concerns - BioWorld MedTech
Broadwood Partners All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote AGAINST Sale to Alcon - MarketScreener
ISS recommends Staar shareholders reject Alcon's $1.5 billion offer - Reuters
Alcon's (ALC) Proposed Acquisition Faces Major Opposition - GuruFocus
ISS Recommends Staar Shareholders Vote Against Alcon Merger - Orange County Business Journal
Broadwood: Proxy advisory firms recommend Staar shareholders vote against sale - TipRanks
Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon - MarketScreener
Oklahoma City NewsThe Oklahoman - FinancialContent
STAAR Surgical (STAA) Shareholders Advised to Reject Alcon's Acq - GuruFocus
Broadwood urges “AGAINST” vote on Alcon deal as advisors dissent - Stock Titan
Broadwood Partners Comments on STAAR Surgical’s Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon - Stock Titan
STAAR Surgical Announces Merger with Alcon Amid Legal Challenges - TradingView
Where Does STAAR Surgical Stand After EVO+ Launch and Recent Share Price Swings? - Yahoo
Large Staar Holders Oppose $1.5B Sale - Orange County Business Journal
Broadwood slams STAAR board over “carelessness” in Alcon sale defense By Investing.com - Investing.com Canada
Broadwood slams STAAR board over “carelessness” in Alcon sale defense - Investing.com
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates STAA, GES, SMLR on Behalf of Shareholders - GlobeNewswire Inc.
STAAR Surgical holders should vote against sale to Alcon, Glass Lewis says - MSN
Investor Group Opposes Alcon's Acquisition of STAAR Surgical (AL - GuruFocus
Broadwood issues letter to Staar Surgical board questioning ‘rush’ in Alcon sale - TipRanks
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale - MarketScreener
Staar Surgical Co Stock (STAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.77%
1.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):